Volume 28, Number 3—March 2022
Research
Case–Control Study of Clostridium innocuum Infection, Taiwan
Table 3
Characteristic | C. innocuum, n = 152 | Clostridioides difficile, n = 304 | p value |
---|---|---|---|
Clinical symptoms | |||
Diarrhea | 56 (36.8) | 217 (71.4) | <0.001 |
Fever | 29 (19.1) | 92 (30.3) | 0.011 |
Abdominal pain | 37 (24.3) | 54 (17.8) | 0.098 |
Vomiting | 13 (8.6) | 29 (9.5) | 0.731 |
Abdominal distension |
25 (16.4) |
41 (13.5) |
0.391 |
Blood testing | |||
Leukocytes, cells/μL† | 10,454 (6,773) | 11,005 (6,788) | 0.783 |
Hemoglobin, g/dL† | 10.7 (2.4) | 9.8 (2.0) | <0.001 |
Platelet count × 1,000/μL† | 243 (110.4) | 231 (135.0) | 0.134 |
CRP, mg/L, median (IQR)‡ |
55.7 (104.7) |
55.7 (97.2) |
0.108 |
Stool routine, no. positive/total (%) | |||
Occult blood | 53/73 (72.6) | 175/216 (81.0) | 0.128 |
Mucus | 9/70 (12.8) | 39/205 (19.0) | 0.241 |
Pus cells |
8/70 (11.4) |
30/205 (14.6) |
0.502 |
Sample site | |||
Stool | 96 (63.2) | 279 (91.8) | <0.001 |
Blood | 7 (4.6) | 1 (0.3) | 0.001 |
Ascites | 13 (8.5) | 8 (2.7) | 0.002 |
Bile§ | 2 (1.3) | 1 (0.3) | 0.219 |
Pus/abscess§ | 16 (10.5) | 3 (1.0) | <0.001 |
Wound/deep tissue§ | 16 (10.5) | 12 (3.6) | 0.006 |
Endocervix§ | 1 (0.7) | 0 | 0.592 |
Semen§ |
1 (0.7) |
0 |
0.592 |
Antimicrobial susceptibility# | |||
Metronidazole | 20/20 (100) | 53/53 (100) | 1.000 |
Clindamycin§ | 30/44 (68.2) | 17/20 (85.0) | 0.158 |
Penicillin§ | 35/44 (79.5) | 12/20 (60.0) | 0.101 |
Ampicillin/sulbactam | 21/21 (100) | 44/44 (100) | 1.000 |
*Values are no. (%) patients except as indicated. Among patients with C. difficile (CD)–associated diarrhea, the CD toxin assay positive rate was 65%. χ2 tests were used to compare all the categorical variables listed in the table except as noted. CRP, C-reactive protein; IQR, interquartile range. †By independent t test. ‡By Mann-Whitney test. §By Fisher exact test. #Data are expressed as susceptible isolate number/total isolate number (%).
1These authors contributed equally to this article.
Page created: January 23, 2022
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.